Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth

This publication has 48 references indexed in Scilit:

• Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
  The Prostate, 2011
• Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation
  International Journal of Oncology, 2011
• Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo
  Asian Journal of Andrology, 2011
• Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression
  Cancer Investigation, 2009
• Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer
  International Journal of Oral and Maxillofacial Surgery, 2007
• Characterization of Monoclonal Antibodies Against GRIM-19, a Novel IFN- β and Retinoic Acid-Activated Regulator of Cell Death
  Journal of Interferon & Cytokine Research, 2002
• Analysis of gene function in somatic mammalian cells using small interfering RNAs
  Methods, 2002
• Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain ofSalmonella typhimurium
  The Journal of Infectious Diseases, 2000
• Analysis of human transcriptomes
  Nature Genetics, 1999
• Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
  Nature Cell Biology, 1999